Outcomes Following Combined Adductoplasty™ and Lapiplasty® (MTA3D)
NCT05587569
This study is recruiting at 9 US sites in 8 states, according to its ClinicalTrials.gov record last updated .
Summary
Prospective, multicenter, unblinded study to evaluate outcomes of the Adductoplasty™ Procedure in combination with the Lapiplasty® Procedure for patients in need of metatarsus adductus and hallux valgus correction. Up to 80 subjects will be treated in this study at up to 13 clinical sites. Patients 14 years of age or older with symptomatic metatarsus adductus and hallux valgus will be eligible to participate based on the inclusion and exclusion criteria defined in the study protocol.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Metatarsus Adductus
- Hallux Valgus
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 14 to 65 years
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- Treace Medical Concepts, Inc.
- Last updated on ClinicalTrials.gov
- May 25, 2025
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Colorado · 1
- Foot and Ankle Center of the Rockies · Greeley, CO
Iowa · 1
- Foot and Ankle Center of Iowa · Ankeny, IA
Maine · 1
- Coastal Maine Foot and Ankle · Yarmouth, ME
Missouri · 1
- JCMG - Jefferson City Medical Group · Jefferson City, MO
North Carolina · 1
- Duke Orthopaedics Arringdon · Morrisville, NC
Ohio · 2
- Ohio Foot and Ankle Center · Canton, OH
- Ohio Foot and Ankle Center · Stow, OH
Pennsylvania · 1
- Greater Pittsburgh Foot and Ankle Center · Wexford, PA
Texas · 1
- Foot and Ankle Associates of North Texas - Keller · Keller, TX
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.